Evidence map›Paper›PMID 34051544›Full record

Trial reportDrug and alcohol dependence2021

Impact of nicotine reduction in cigarettes on smoking behavior and exposure: Are there differences by race/ethnicity, educational attainment, or gender?

Dana M Carroll, Bruce R Lindgren, Sarah S Dermody, Rachel Denlinger-Apte, Andrew Egbert, Rachel N Cassidy, Tracy T Smith, Lauren R Pacek, Alicia M Allen, Jennifer W Tidey and 4 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Pooled it
  2. Trial
  3. Trial
  4. Manipulation of Menthol and Nicotine Content in Cigarettes: Effects on Smoking Behavior and Toxicant Exposure in Women Menthol Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Trial
  5. Article
  6. American Indian Persons' Perspectives on Various Smoking Cessation Aids and Approaches: A Community-Engaged Qualitative Research Study.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Prioritize Health Equity When Implementing a Nicotine Product Standard.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Dana M CarrollDivision of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN, United States. Electronic address: dcarroll@Umn.edu.
Bruce R LindgrenMasonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.
Sarah S DermodyDepartment of Psychology, Ryerson University, Toronto, ON, Canada.
Rachel Denlinger-ApteDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Andrew EgbertMasonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.
Rachel N CassidyDepartment of Behavioral and Social Sciences, Brown University, Providence, RI, United States.
Tracy T SmithDepartment Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.
Lauren R PacekDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, United States.
Alicia M AllenDepartment of Family and Community Medicine, University of Arizona College of Medicine, Tucson, AZ, United States.
Jennifer W TideyDepartment of Behavioral and Social Sciences, Brown University, Providence, RI, United States.
Michael J ParksInstitute for Translational Research in Children's Mental Health, University of Minnesota, Minneapolis, MN, United States.
Joseph S KoopmeinersDivision of Biostatistics, School of Public Health, University of Minnesota, United States.
Eric C DonnyDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Dorothy K HatsukamiDepartment of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, MN, United States.
University of Minnesota · USBrown University · USUniversity of Minnesota Medical Center · USWake Forest University · USDuke University · USMedical University of South Carolina · USToronto Metropolitan University · CAUniversity of Arizona · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIAU54DA031659 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HATSUKAMI, DOROTHY K · 2011 to 2022
$64.7M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Impact of e-cigarette characteristics on reinforcement and tobacco use patterns among current smokersK01DA047433 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SMITH, TRACY TAYLOR · 2019 to 2023
$988k
Mobile health interventions for varenicline adherence among HIV-positive smokersK01DA043413 · NIDA · DUKE UNIVERSITY · PI PACEK, LAUREN RENEE · 2017 to 2021
$860k
Laying the Foundation for Personalized Smoking Cessation Treatment in the American Indian PopulationK01MD014795 · NIMHD · UNIVERSITY OF MINNESOTA · PI CARROLL, DANA MOWLS · 2020 to 2024
$684k
NCATS NIH HHS UL1 TR002494NCI NIH HHS P30 CA077598NIDA NIH HHS K01 DA043413NIDA NIH HHS K01 DA047433NIDA NIH HHS U54 DA031659NIMHD NIH HHS K01 MD014795
6 · The paper itself

Abstract

backgroundLowering nicotine in cigarettes may reduce smoking prevalences; however, it is not known whether an immediate or gradual reduction in nicotine is the optimal approach for all population groups.

objectivesWe examined whether the optimal approach to nicotine reduction depended on the education, gender, or race of people who smoke and whether the optimal approach differentially benefited people who smoke based on their education, gender, or race.

methodsSecondary analysis was conducted on a randomized clinical trial (N = 1250) comparing (1) immediate reduction from 15.5 to 0.4 mg of nicotine per gram of tobacco(mg/g);(2) gradual reduction to 0.4 mg/g;(3) control group with normal nicotine cigarettes(15.5 mg/g). Outcomes included cigarettes per day(CPD), carbon monoxide(CO), total nicotine equivalents(TNE), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides(NNAL), phenanthrene tetraol(PheT), N-Acetyl-S-(2-cyanoethyl)-l-cysteine(CEMA). Data were analyzed as area under the curve(AUC).

resultsResults were presented by education (High school[HS] or less n = 505, more than HS n = 745), gender (males n = 701, females n = 549), and race (Black participants n = 373,White participants n = 758). Regardless of education, gender, and race, CPD, CO, TNE, NNAL, PheT, and CEMA were lower in immediate versus gradual nicotine reduction. Comparing immediate versus the control, outcomes were lower for all subgroups; however, the magnitude of the effect for TNE varied by race. Specifically, geometric mean of the AUC of TNE in immediate versus gradual was 49 % lower in Black participants and 61 % lower in White participants (p-value = 0.047).

conclusionsImmediately reducing nicotine in cigarettes has the potential to benefit people who smoke across lower and higher educational attainment, male and female gender, and Black and White race.

Indexed as

Tobacco ProductsTobacco Use DisorderBiomarkersEthnicityFemaleHumansMaleNicotineSmokingBiomarkersNicotineGender differencesHealth disparitiesMinoritized groupsNicotineTobacco controlTobacco regulatory science

Identifiers

PMID34051544
PMCPMC8282676
OpenAlexW3165001094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.